RPG Life Sciences Limited Total Assets
RPG Life Sciences Limited total assets. Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) holds total assets worth Rs7.93 Billion INR (≈ $85.78 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see RPGLIFE stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of RPG Life Sciences Limited (2005–2026)
Total assets of RPG Life Sciences Limited from 2005 to 2026. This chart illustrates how RPG Life Sciences Limited's total assets have evolved over time, based on quarterly financial data. See today's stock price for RPG Life Sciences Limited for real-time trading data and today's change.
RPG Life Sciences Limited - Asset Composition Analysis
RPG Life Sciences Limited Total Assets Breakdown (March 2026)
RPG Life Sciences Limited total assets breakdown as of March 2026. RPG Life Sciences Limited's total assets of Rs7.93 Billion consist of 70.5% current assets and 29.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 19.0% |
| Accounts Receivable | Rs1.17 Billion | 14.7% |
| Inventory | Rs1.24 Billion | 15.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs81.10 Million | 1.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how RPG Life Sciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore RPG Life Sciences Limited working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RPG Life Sciences Limited's current assets represent 70.5% of total assets in 2026, an increase from 29.2% in 2005.
- Cash Position: Cash and equivalents constituted 19.0% of total assets in 2026, up from 0.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 15.6% of total assets.
RPG Life Sciences Limited Competitors by Total Assets
Key competitors of RPG Life Sciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
RPG Life Sciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.48 | 3.88 | 2.21 |
| Quick Ratio | 2.71 | 3.11 | 1.47 |
| Cash Ratio | 0.00 | 1.17 | 0.00 |
| Working Capital | Rs3.99 Billion | Rs3.45 Billion | Rs961.60 Million |
RPG Life Sciences Limited - Advanced Valuation Insights
This section examines the relationship between RPG Life Sciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.21 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 20.6% |
| Total Assets | Rs7.93 Billion |
| Market Capitalization | $452.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values RPG Life Sciences Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: RPG Life Sciences Limited's assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for RPG Life Sciences Limited (2005–2026)
The table below shows the annual total assets of RPG Life Sciences Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs7.93 Billion ≈ $85.78 Million |
+20.58% |
| 2025-03-31 | Rs6.58 Billion ≈ $71.14 Million |
+28.26% |
| 2024-03-31 | Rs5.13 Billion ≈ $55.46 Million |
+22.30% |
| 2023-03-31 | Rs4.19 Billion ≈ $45.35 Million |
+21.69% |
| 2022-03-31 | Rs3.45 Billion ≈ $37.27 Million |
+13.59% |
| 2021-03-31 | Rs3.03 Billion ≈ $32.81 Million |
+13.74% |
| 2020-03-31 | Rs2.67 Billion ≈ $28.85 Million |
+6.17% |
| 2019-03-31 | Rs2.51 Billion ≈ $27.17 Million |
-13.74% |
| 2018-03-31 | Rs2.91 Billion ≈ $31.50 Million |
+18.27% |
| 2017-03-31 | Rs2.46 Billion ≈ $26.63 Million |
+20.00% |
| 2016-03-31 | Rs2.05 Billion ≈ $22.19 Million |
+4.23% |
| 2015-03-31 | Rs1.97 Billion ≈ $21.30 Million |
+0.43% |
| 2014-03-31 | Rs1.96 Billion ≈ $21.20 Million |
-4.71% |
| 2013-03-31 | Rs2.06 Billion ≈ $22.25 Million |
+12.50% |
| 2012-03-31 | Rs1.83 Billion ≈ $19.78 Million |
-4.19% |
| 2011-03-31 | Rs1.91 Billion ≈ $20.64 Million |
+14.06% |
| 2010-03-31 | Rs1.67 Billion ≈ $18.10 Million |
-0.33% |
| 2009-03-31 | Rs1.68 Billion ≈ $18.16 Million |
-4.27% |
| 2008-03-31 | Rs1.75 Billion ≈ $18.97 Million |
-14.63% |
| 2007-03-31 | Rs2.05 Billion ≈ $22.22 Million |
-6.36% |
| 2006-03-31 | Rs2.19 Billion ≈ $23.73 Million |
-6.71% |
| 2005-03-31 | Rs2.35 Billion ≈ $25.44 Million |
-- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more